Psyence Biomedical Receives Nasdaq Extension to Meet Continued Listing Rules

MT NewswiresNov 20 09:47 ET

Express News | Psyence Biomedical Ltd - Nasdaq Grants Psyence Biomed Extension Until December 31, 2024

ReutersNov 20 07:32 ET

Express News | Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing

ReutersNov 20 07:30 ET

Psyence Biomedical Announces 1-For-75 Share Consolidation Will Begin Trading On A Post-Consolidated Basis At The Opening Of The Market On Tuesday, November 26, 2024

BenzingaNov 19 16:24 ET

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation

GlobeNewswireNov 19 16:05 ET

Express News | Psyence Biomedical Announces Results From Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination From Nasdaq

ReutersNov 12 16:30 ET